Warning: Invalid argument supplied for foreach() in /home/urs/public_html/hafeli_lab/publications.php on line 39


To check out the content of a publication, please click on the bolded title.

Publications Books Book Chapters Patents Dissertations

Publications

    2018

  1. Ranamukhaarachchi S, Padeste C, Häfeli UO, Stoeber B, Cadarso VJ (2018). Design considerations of a hollow microneedle-optofluidic biosensing platform incorporating enzyme-linked assays. Journal of Micromechanics and Microengineering 28, 024002
  2. Nosrati Z, Li N, Michaud F, Ranamukhaarachchi S, Karagiosov SK, Soulez G, Martel S, Saatchi K, Häfeli UO (2018). Development of a Coflowing Device for the Size-Controlled Preparation of Magnetic-Polymeric Microspheres as Embolization Agents in Magnetic Resonance Navigation Technology. ACS Biomaterials Science & Engineering, in press
  3. Schmitt V, Rodriguez-Rodriguez C, Hamilton JL, Shenoi RA, Schaffer P, Sossi V, Kizhakkedathu JN, Saatchi K, Häfeli UO (2018). Quantitative SPECT Imaging and Biodistribution Point to Molecular Weight Independent Tumor Uptake For Some Long-Circulating Polymer Nanocarriers. RSC Advances 8, 5586-5595
  4. 2017

  5. Buchwalder C, Rodriguez-Rodriguez C, Schaffer P, Karagiozov S, Saatchi K, Häfeli UO (2017). A New Tetrapodal 3-Hydroxy-4-Pyridinone Ligand for Complexation of Zirconium-89 for Positron Emission Tomography (PET) Imaging. Dalton Trans 46, 9654-9663
  6. Bokharaei M, Saatchi K, Häfeli UO (2017). A Single Microfluidic Chip with Dual Surface Properties for Protein Drug Delivery. Int J Pharm 521, 84-91
  7. Esquinas P, Uribe C, Gonzales M, Rodriguez-Rodriguez C, Häfeli UO, Celler A (2017). Accuracy of Rhenium-188 SPECT/CT activity quantification for applications in radionuclide therapy using clinical reconstruction methods. Physics in Medicine & Biology 62, 6379-6396
  8. Schmitt V, Szeitz A, Klassen TL, Häfeli UO (2017). An Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of Vancomycin Requiring Only 2 µL of Rabbit Serum. American Journal of Analytical Chemistry 8, 553-563
  9. Saatchi K, Tod SE, Leung D, Nicholson KE, Andreu I, Buchwalder C, Schmitt V, Häfeli UO, Gray S (2017). Characterization of Alendronic- and Undecylenic Acid Coated Magnetic Nanoparticles for the Targeted Delivery of Rosiglitazone to Subcutaneous Adipose Tissue. Nanotechnol Biol Med 13(2) 559-568
  10. Auyeung A, Casillas-Santana MA, Martinez-Castanon GA, Slavin YN, Zhao W, Asnis J, Häfeli UO, Bach H (2017). Effective control of molds using a combination of nanoparticles. PLOS One 12(1): e0169940
  11. Schneider T, Löwa A, Karagiozov S, Sprenger L, Gutierrez L, Esposito T, Marten GU, Saatchi K, Häfeli UO (2017). Facile Microwave Synthesis of Uniform Magnetic Nanoparticles with Minimal Sample Processing. J Magn Mag Mat 421, 283-291
  12. Dutz S, Hayden ME, Häfeli UO (2017). Fractionation of magnetic microspheres in a microfluidic spiral: Interplay between magnetic and hydrodynamic forces. PLOS One 12(1): e0169919
  13. Le TN, Straatman L, Yanai A, Garnis C, Häfeli UO, Westerberg BD, Gregory-Evans K (2017). Magnetic stem cell targeting to the inner ear. J Magn Mag Mat 443, 385-396
  14. Slavin YN, Asnis J, Häfeli UO, Bach H (2017). Metal nanoparticles: understanding the mechanisms behind antibacterial activity. Journal of Nanobiotechnology 15:65
  15. Esquinas P, Rodriguez-Rodriguez C, de la Vega J, Bokharaei M, Saatchi K, Shirmohammad M, Häfeli UO, Sossi V, Celler A (2017). Re-188 image performance assessment using small animal multi-pinhole SPECT/PET/CT system. Physica Medica 33(1) 26-37
  16. Arami H, Teeman E, Troksa A, Bradshaw H, Saatchi K, Tomitaka A, Gambhir SS, Häfeli UO, Liggitt D, Krishnan KM (2017). Tomographic Magnetic Particle Imaging (MPI) of Cancer Targeted Nanoparticles. Nanoscale 7, 18723-18730
  17. 2016

  18. Bokharaei M, Schneider T, Dutz S, Stone R, Mefford OT, Häfeli UO (2016). 3D Simulation of Droplet Formation and Production of Monodispersed Magnetic Polymeric Microspheres in a Microfluidic Chip. Microfluidics and Nanofluidics 20, 1-14
  19. Gong T, Wang Z, Zhang Y, Zhang Y, Yan Y, Liu Y, Liu X, Wang Y, Yang X, Zhao L, Hou M, Zhang H, Ruse ND, Troczynski T, Häfeli UO (2016). A comprehensive study of osteogenic calcium phosphate silicate cement: material characterization and in vitro/in vivo testing. Advanced Healthcare Materials 5, 457-466
  20. Ranamukhaarachchi SA, Lehnert S, Ranamukhaarachchi SL, Sprenger L, Schneider T, Mansoor I, Rai K, Häfeli UO, Stoeber B (2016). A Micromechanical Comparison of Human and Porcine Skin Before and After Preservation by Freezing. Scientific reports 6:32074
  21. Esquinas P, Tanguay JF, Gonzalez M, Vuckovic M, Rodriguez-Rodriguez C, Häfeli UO, Celler A (2016). Accuracy, Reproducibility and Uncertainty Analysis of Thyroid Probe-Based Activity Measurements for Determination of Dose Calibrator Settings. Med Phys 43 (12) 6309-6321
  22. Ranamukhaarachchi SA, Schneider T, Lehnert S, Sprenger L, Campbell J, Mansoor I, Lai J, Rai K, Dutz J, Häfeli UO, Stoeber B (2016). Development and Validation of an Artificial Mechanical Skin Model for the Study of Interactions between Skin and Microneedles. Macromolecular Materials and Engineering 301, 306-314
  23. Ranamukhaarachchi SA, Padeste C, Dübner M, Häfeli UO, Stoeber B, Cadarso VJ (2016). Integrated hollow microneedle-optofluidic biosensor for therapeutic drug monitoring in sub-nanoliter volumes. Scientific reports 6:29075
  24. Baker JHE, McPhee KC, Moosvi FS, Saatchi K, Häfeli UO, Minchinton AI, Reinsberg SA (2016). Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent Hyperbranched Polyglycerol (HPG-GdF). Contrast Media & Molecular Imaging 11, 77-88
  25. Gong T, Chen Y, Zhang Y, Zhang Y, Liu X, Troczynski T, Häfeli UO (2016). Osteogenic and anti-osteoporotic effects of risedronate-added calcium phosphate silicate cement. Biomedical Materials 11 (4) 045002
  26. 2015

  27. Mansoor I, Lai J, Ranamukhaarachchi S, Schmitt V, Lambert D, Dutz JP, Häfeli UO, Stoeber B (2015). A microneedle-based method for the characterization of diffusion in skin tissue using doxorubicin as a model drug. Biomed Microdev 17, 61
  28. Zhong Y, Leung V, Wan LY, Dutz S, Ko FK, Häfeli UO (2015). Electrospun magnetic nanofibre mats - a new bondable biomaterial using remotely activated magnetic heating. J Magn Mag Mat 380, 330-334
  29. Sprenger L, Dutz S, Schneider T, Odenbach S, Häfeli UO (2015). Simulation and experimental determination of the online separation of blood components with the help of microfluidic cascading spirals. Biomicrofluidics 9, 044110
  30. de la Vega J, Häfeli UO (2015). Utilization of Nanoparticles as X-Ray Contrast Agents for Diagnostic Imaging Applications. Contrast Media & Molecular Imaging 10, 81-95
  31. 2014

  32. Kiang TK, Häfeli UO, Ensom MHH (2014). A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring. Clin Pharmacokinet 53 (8), 695-730
  33. Gong T, Wang Z, Zhang Y, Sun C, Yang Q, Troczynski T, Häfeli UO (2014). Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system. J Biomed Mater Res Part A 102A (7) 2295-2304
  34. 2013

  35. Mansoor I, Liu Y, Häfeli UO, Stoeber B (2013). Arrays of hollow out-of-plane microneedles made by metal electrodeposition onto solvent cast conductive polymer structures. Journal of Micromechanics and Microengineering 23, 085011
  36. Bleul R, Thiermann R, Marten GU, House MJ, Pierre TG, Häfeli UO, Maskos M (2013). Continuously manufactured magnetic polymersomes - a versatile tool (not only) for targeted cancer therapy. Nanoscale 5, 11385-11393
  37. Bashar AE, Metcalfe A, Yanai A, Laver C, Häfeli UO, Gregory-Evans CY, Moritz OL, Matsubara JA, Gregory-Evans K (2013). Influence of iron oxide nanoparticles on innate and genetically modified secretion profiles of mesenchymal stem cells. IEEE Transactions on Magnetics 49, 389-393
  38. Bleul R, Thiermann R, Saatchi K, Häfeli UO, Maskos M (2013). Multifunctional nanocarriers for biomedical applications. Proc of SPIE 8595, 1N-9
  39. de la Vega J, Elischer P, Schneider T, Häfeli UO (2013). Uniform microspheres: Definition of monodispersity, methods of formation and applications. Nanomedicine 8, 265-285
  40. 2012

  41. Dutz S, Hayden ME, Schaap A, Stoeber B, Häfeli UO (2012). A microfluidic spiral for size-dependent fractionation of magnetic microspheres. Journal of Magnetism and Magnetic Materials 324, 3791-3798
  42. Laurent S, Burtea C, Thirifays C, Häfeli UO, Mahmoudi M (2012). Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications. PloS ONE 7, e29997
  43. Misri R, Meier D, Yung A, Kozlowski P, Saatchi K, Häfeli UO (2012). Development and evaluation of dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomed Nanotechnol Biol Med 8, 1007-1016
  44. Yanai A, Häfeli UO, Metcalfe A, Soema P, Addo L, Gregory-Evans CY, Po K, Shan XH, Moritz O, Gregory-Evans K (2012). Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles. Cell Transplantation 21, 1137-1148
  45. Mansoor I, Häfeli UO, Stoeber B (2012). Hollow out-of-plane polymer microneedles made by solvent casting for transdermal drug delivery. J MEMS 21, 44-52
  46. Saatchi K, Soema P, Gelder N, Misri R, McPhee K, Baker J, Reinsberg SA, Brooks DE, Häfeli UO (2012). Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility and tumor uptake. Bioconjugate Chemistry 23, 372-381
  47. Saatchi K, Gelder N, Gershkovich P, Sivak O, Wasan KM, Kainthan RK, Brooks DE, Häfeli UO (2012). Long-circulating nontoxic cardiac blood pool imaging agent based on hyperbranched polyglycerols. International Journal of Pharmaceutics 422, 418-427
  48. Misri R, Saatchi K, Häfeli UO (2012). Nanoprobes for hybrid SPECT/MR molecular imaging. Nanomedicine: Nanotechnology, Biology and Medicine 7, 719-733
  49. Kiang TK, Schmitt V, Ensom MH, Chua B, Häfeli UO (2012). Therapeutic drug monitoring in interstitial fluid: a feasibility study using a comprehensive panel of drugs. Journal of Pharmaceutical Sciences 101, 4642-4652
  50. 2011

  51. Burrill J, Häfeli UO, Liu DM (2011). Advances in radioembolization - Embolics and radioisotopes. Journal of Nuclear Medicine and Radiation Therapy 2, 1000107
  52. Mansoor I, Häfeli UO, Stoeber B (2011). Arrays of solvent cast hollow out-of-plane microneedles for drug delivery. In: IEEE MEMS 2011, Cancun, Mexico, 1027-1030
  53. Häfeli UO, Ensom MH, Kiang TK, Stoeber B, Chua B, Pudek M, Schmitt V (2011). Comparison of vancomycin concentrations in blood and interstitial fluid: a possible model for less invasive therapeutic drug monitoring. Clinical Chemistry and Laboratory Medicine 49, 2123-2125
  54. Schneider T, Chapman GH, Häfeli UO (2011). Effects of chemical and physical parameters in the generation of microspheres by hydrodynamic flow focusing. Colloids and Surfaces B: Biointerfaces 87, 361-368
  55. Misri R, Saatchi K, Ng SSW, Kumar U, Häfeli UO (2011). Evaluation of 111In labeled antibodies for SPECT imaging of mesothelin. Nucl Med Biol 38, 885-896
  56. Laurent S, Dutz S, Häfeli UO, Mahmoudi M (2011). Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166, 8-23
  57. Boros E, Lin Y-HS, Ferreira CL, Patrick BO, Häfeli UO, Adam MJ, Orvig C (2011). One to chelate them all: Towards a versatile, all-encompassing bifunctional chelator for 64Cu, 99mTc, 186/188Re, 55Co. Dalton Trans 40, 6253-6259
  58. Misri R, Saatchi K, Häfeli UO (2011). Radiolabeling of fab and f(ab)2 antibody fragments with 99mTc(I) tricarbonyl core using a new bifunctional tridentate ligand. Nucl Med Commun 32, 324-329
  59. 2010

  60. Mahmoudi M, Simchi A, Imani M, Shokrgozar M, Milani A, Häfeli UO, Stroeve P (2010). A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids and Surfaces B: Biointerfaces 75, 300-309
  61. Häfeli UO, Saatchi K, Elischer P, Misri R, Bokharaei M, Labiris NR, Stoeber B (2010). Lung perfusion imaging with monosized biodegradable microspheres. Biomacromolecules 11, 561-567
  62. Schmitt V, Rodrigues B, Häfeli UO, Saatchi K (2010). Study of the binding capacity of heparin functionalized magnetic microparticles for cardiac lipoprotein lipase and their preliminary evaluation ex vivo in rat hearts. AIP Conf Proc 1311, 408-415
  63. Dengler M, Saatchi K, Dailey JP, Matsubara J, Mikelberg FS, Häfeli UO, Yeung SN (2010). Targeted delivery of magnetic cobalt nanoparticles to the eye following systemic administration. AIP Conf Proc 1311, 329-336
  64. 2009

  65. Häfeli UO, Riffle JS, Harris LA, Carmichael AY, Mark F, Dailey JP, Bardenstein D (2009). Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharmaceutics 6, 1417-1428
  66. Boros E, Häfeli UO, Patrick BO, Adam MJ, Orvig C (2009). Design, synthesis and imaging of small amphiphilic rhenium and 99mTechnetium tricarbonyl complexes. Bioconjugate Chemistry 20, 1002-1009
  67. Song KY, Chiao M, Stoeber B, Häfeli U, Gupta MM, Zhang WJ (2009). Formation of uniform microspheres using a perforated silicon membrane: a preliminary study. Journal of Medical Devices 3, 034503
  68. Bowen ML, Lim NC, Ewart CB, Misri R, Ferreira CL, Häfeli UO, Adam MJ, Orvig C (2009). Glucosamine conjugates bearing N,N,O-donors: Potential imaging agents utilizing the [M(CO)3] core (M = Re, Tc). Dalton Trans 42, 9216-9227
  69. Häfeli UO, Mokhtari A, Liepmann D, Stoeber B (2009). In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery. Biomedical Microdevices 11, 943-950
  70. Bowen ML, Chen ZF, Roos AM, Misri R, Häfeli UO, Adam MJ, Orvig C (2009). Long-chain rhenium and technetium glucosamine conjugates. Dalton Trans 42, 9228-9236
  71. Tokoro H, Nakabayashi T, Fujii S, Zhao H, Häfeli UO (2009). Magnetic particles with high magnetization useful for immunoassay. J Magn Magn Mater 321, 1676-1678
  72. Mahmoudi M, Shokrgozar M, Simchi A, Imani M, Milani A, Stroeve P, Vali H, Häfeli UO, Sasanpour P, Bonakdar S (2009). Multiphysics flow modeling and in vitro toxicity of iron oxide nanoparticles coated with polyvinyl alcohol. J Phys Chem C 113, 2322 - 2331
  73. Zhao H, Saatchi K, Häfeli UO (2009). Preparation of biodegradable magnetic microspheres with poly(lactic acid) coated magnetite. J Magn Magn Mater 321, 1356-1363
  74. Saatchi K, Häfeli UO (2009). Radiolabeling of biodegradable polymeric microspheres with [99mTc(CO)3] and in vivo evaluation using microSPECT/CT imaging. Bioconjug Chem 20, 1209-1217
  75. Mahmoudi M, Simchi A, Imani M, Häfeli UO (2009). Superparamagnetic iron oxide nanoparticles with rigid cross-linked polyethylene glycol fumarate coating for application in imaging and drug delivery. J Phys Chem C 113, 8124-8131
  76. 2008

  77. Saatchi K, Häfeli UO (2008). Magnetic Carriers Conference 2008. NanoMedicine 3, 415-421
  78. Schneider T, Zhao H, Jackson JK, Chapman GH, Dykes J, Hafeli UO (2008). Use of hydrodynamic flow focusing for the generation of biodegradable camptothecin-loaded polymer microspheres. J Pharm Sci 97, 4943-4954
  79. 2007

  80. Häfeli UO, Unnithan J, Pauer GJ, Prayson RA (2007). Fibrin glue system for adjuvant brachytherapy of brain tumors with 188 Re- and 186 Re-labeled microspheres. Eur J Pharm Biopharm 65, 282-288
  81. Saatchi K, Häfeli UO (2007). One-pot syntheses, coordination and characterization of application-specific biodegradable ligand-polymers. Dalton Trans 39, 4439-4445
  82. Zhao H, Gagnon J, Häfeli UO (2007). Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres. Biomagn Res Technol 5:2
  83. Häfeli UO, Gilmour K, Zhou A, Lee S, Hayden ME (2007). Simulation and implementation of magnetic bandages for drug targeting: Button magnets versus Halbach arrays. Journal of Magnetism and Magnetic Materials 311, 323 - 329
  84. 2006

  85. Hayden ME, Häfeli UO (2006). 'Magnetic bandages' for targeted delivery of therapeutic agents. Journal of Physics and Condensed Matter 18, S2877-S2891
  86. 2005

  87. Zhang H, Häfeli UO (2005). Experimentation and modeling of electrodeposition of Rhenium-188 on medical 316L stainless steel wires. Plating and Surface Finishing 92, 40 - 44
  88. Häfeli UO, Lobedann MA, Steingroewer J, Moore, Riffle JS (2005). Optical method for measurement of magnetophoretic mobility of individual magnetic microspheres in defined magnetic field. J Magn Magn Mater 293, 224 - 239
  89. Yu JF, Häfeli UO, Xiao J, Li S, Dong M, Yin D, Wang Y (2005). Radiolabeling of poly(histidine)-derivatized biodegradable microspheres with rhenium-188 tricarbonyl complex [188Re(CO)3(H2O)3]. Nucl Med Commun 26, 453 - 458
  90. Algur E, Macklis RM, Häfeli UO (2005). Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines. Int J Radiat Oncol Biol Phys 61, 535-542
  91. 2004

  92. Häfeli UO, Zhang H, Bahrehmand F, Reynaert N (2004). Development of an automated electroplater and dosimetry system for the electrodeposition and quality control of radioactive stents. Applied Radiation & Isotopes 61, 1313-1321
  93. Häfeli UO (2004). Magnetically modulated therapeutic systems. International Journal of Pharmaceutics 277, 19-24
  94. Iacob G, Rotariu O, Strachan NJC, Häfeli UO (2004). Magnetizable needles and wires - modeling an efficient way to target magnetic microspheres in vivo. Biorheology 41, 599-612
  95. Zhang H, Häfeli UO (2004). Preparation and characterization of radioactive Co/188Re stents intended for lung cancer treatment using an electrodeposition method. Journal of Medical Engineering Technology 28, 197-204
  96. Cao J, Wang Y, Yu J, Xia J, Zhang C, Yin D, Häfeli UO (2004). Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. Journal of Magnetism and Magnetic Materials 277, 165-174
  97. Häfeli UO, Subbarayan M, Mukhtar H (2004). Response to Letters to the Editor: Cooking Annexin V: A simple 1-pot procedure to destroy its phosphatidylserine-binding activity. Journal of Nuclear Medicine 45, 1098-1099
  98. Gupta S, Adhami VM, Subbarayan M, MacLennan GT, Lewin JS, Häfeli UO, Fu P, Mukhtar H (2004). Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model. Cancer Research 64 3334-3343
  99. 2003

  100. Yu J, Sands MJ, Dong Y, Häfeli UO (2003). 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer. Applied Radiation & Isotopes 58, 567-573
  101. Subbarayan M, Häfeli UO, Feyes DK, Unnithan J, Emancipator SN, Mukhtar H (2003). A simplified method for the preparation of 99mTc-annexin V and its biological evaluation for in vivo imaging of apoptosis after photodynamic therapy. Journal of Nuclear Medicine 44, 650-656
  102. Kaminski MD, Nunez L, Ghebremeskel AN, Eastman JA, Chang F, Chien TH, Kasza KE, Fischer PF, Rosengart AJ, McDonald L, Xie Y, Johns L, Pytel P, Häfeli UO (2003). Magnetically responsive microparticles for targeted drug and radionuclide delivery. A review of recent progress and future challenges. Argonne, IL: Argonne National Laboratory ANL-03/28, 1-92
  103. Häfeli UO, Yu J, Farudi F, Li Y, Tapolsky G (2003). Radiolabeling of magnetic targeted carriers (MTC) with indium-111. Nuclear Medicine & Biology 30, 761-769
  104. 2002

  105. Häfeli UO, Ciocan R, Dailey JP (2002). Characterization of magnetic particles and microspheres and their magnetophoretic mobility using a digital microscopy method. European Cells and Materials 3 Suppl. 2, 24-27
  106. Yu JF, Häfeli UO, Dong Y, Sands MJ, Li YH, Failing S, Leakakos T, Tapolsky G (2002). Radiolabeling of magnetic targeted carriers with several therapeutic and imaging radioisotopes. Eur. Cells Mat., 3 Suppl. 2 16-18
  107. Reynaert N, Häfeli UO (2002). Response to Dr. Janicki's letter to the editor [Med. Phys. 29, 260 (2002)]. Medical Physics 29, 261
  108. 2001

  109. Häfeli UO, Pauer GJ, Miller DD (2001). Feasibility study for the treatment of metastatic prostate cancer with the radioactive antiandrogen I-125-bicalutamide (I-125 Casodex). Journal of Labelled Compounds and Radiopharmaceuticals 44, S670-S672
  110. Rudershausen S, Häfeli UO, Grüttner C, Teller J (2001). Novel chelator containing particles specific for controlled radioisotope delivery. Journal of Labelled Compounds and Radiopharmaceuticals 44, S838-S840
  111. Häfeli U, Pauer G, Failing S, Tapolsky G (2001). Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. Journal of Magnetism and Magnetic Materials 225, 73-78
  112. Reynaert N, Häfeli U (2001). Self-absorption correction for P-32, Au-198 and Re-188 stents: Dose point kernel calculations versus Monte Carlo. Medical Physics 28, 1883-1898
  113. Häfeli UO, Roberts WK, Pauer GJ, Kraeft SK, Macklis RM (2001). Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation. Applied Radiation and Isotopes 54, 869-879
  114. 2000

  115. Evans EE, Häfeli UO, Wusirika R, Morrison PW (2000). Diamond like carbon coatings for rhenium wires and foils. Amorphous and nanostructured carbon 593, 433-438
  116. Häfeli UO, Roberts WK, Meier DS, Ciezki JP, Pauer GJ, Lee EJ, Weinhous M (2000). Dosimetry of a W-188/Re-188 beta line source for endovascular brachytherapy. Medical Physics 27, 668-675
  117. Erzurum VZ, Häfeli UO, Hirko MK, Schmidt SP, Rubin JR (2000). Local application of beta-particle radiation to reduce venous anastomotic intimal hyperplasia in polytetrafluorethylene arteriovenous fistulas. Vascular Surgery 34, 377-383
  118. 1999

  119. Schütt W, Grüttner C, Teller J, Westphal F, Häfeli UO, Paulke B, Goetz P, Finck W (1999). Biocompatible magnetic polymer carriers for in vivo radionuclide delivery. Artificial Organs 23, 98-103
  120. Häfeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, Day DE (1999). Hepatic tumor radioembolization in a rat model using radioactive rhenium (186Re/188Re) glass microspheres. International Journal of Radiation Oncology Biology Physics 44, 189-199
  121. Häfeli UO, Pauer GJ (1999). In vitro and in vivo toxicity of magnetic microspheres. Journal of Magnetism and Magnetic Materials 194, 76-82
  122. Roberts WK, Häfeli UO (1999). Modeling rhenium-186 and rhenium-188 distribution in a neutron-activated rhenium wire and effect of the distribution on beta dosimetry in a water phantom. Applied Radiation and Isotopes 51, 543-549
  123. Ciezki JP, Häfeli UO, Song P, Urankar-Nagy N, Ratliff NB, Rybicki L, Brill K, Meier D (1999). Parenchymal cell proliferation in coronary arteries after PTCA: A human tissue bank study. International Journal of Radiation Oncology Biology Physics 45, 963-968
  124. Häfeli UO, Lee EJ, Ciezki J, Pauer GJ, Weinhous MS (1999). Suitability of beta-emitting rhenium for inhibiting restenosis in coronary arteries. Journal of Brachytherapy International 15, 1-11
  125. 1998

  126. Häfeli UO, Warburton MC, Landau U (1998). Electrodeposition of radioactive rhenium onto stents to prevent restenosis. Biomaterials 19, 925-933
  127. Conzone SD, Häfeli UO, Day DE, Ehrhardt GJ (1998). Preparation and properties of radioactive rhenium glass microspheres intended for in-vivo radioembolization therapy. Journal of Biomedical Materials Research 42, 617-625
  128. 1997

  129. Schütt W, Grüttner C, Häfeli UO, Zborowski M, Teller J, Putzar H, Schümichen C (1997). Applications of magnetic targeting in diagnosis and therapy - possibilities and limitations. A mini-review. Hybridoma 16, 109-117
  130. Gallo JM, Häfeli U (1997). Correspondence re: A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting. Cancer Research 57, 3063-3064
  131. 1995

  132. Häfeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995). Effective targeting of magnetic radioactive Y-90-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nuclear Medicine and Biology - International Journal of Radiation Applications and Instrumentation Part B 22, 147-155
  133. Häfeli UO, Pauer GJ, Macklis RM (1995). Treatment of mouse tumors with radioactive magnetic microspheres: Model for intracavitary radiotherapy. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 22, 89-90
  134. 1994

  135. Häfeli UO, Sweeney SM, Beresford BS, Sim EH, Macklis RM (1994). Magnetically directed poly(lactic acid) Y-90-microspheres: Novel agents for targeted intracavitary radiotherapy. Journal of Biomedical Materials Research 28, 901-908
  136. 1992

  137. Häfeli U, Atcher RW, Morris CE, Beresford B, Humm JL, Macklis RM (1992). Polymeric radiopharmaceutical delivery systems. Radioactivity & Radiochemistry 3, 11-14
  138. 1991

  139. Häfeli UO, Tiefenauer LX, Schubiger PA, Weder HG (1991). A lipophilic complex with Re-186/Re-186 incorporated in liposomes suitable for radiotherapy. Nuclear Medicine and Biology - International Journal of Radiation Applications and Instrumentation Part B 18, 449-454


Books


Book Chapters


Patents

Last Modified: December 05, 2012.
Back to Top